ES8207176A1 - Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5) - Google Patents
Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5)Info
- Publication number
- ES8207176A1 ES8207176A1 ES507317A ES507317A ES8207176A1 ES 8207176 A1 ES8207176 A1 ES 8207176A1 ES 507317 A ES507317 A ES 507317A ES 507317 A ES507317 A ES 507317A ES 8207176 A1 ES8207176 A1 ES 8207176A1
- Authority
- ES
- Spain
- Prior art keywords
- naphthyridine
- derivatives
- indolo
- hexahydro
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- X-Ray Techniques (AREA)
- Carbon And Carbon Compounds (AREA)
- Secondary Cells (AREA)
- Electrolytic Production Of Metals (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE LA HEXAHIDRO-2,3,3A,4,5,6-1H-INDOL (3,2,1-DE) (NAFTIRIDINA-1,5), EN FORMA DE RACEMATOS Y DE ENANTIOMEROS, ASI COMO DE SUS SALES DE ADICION DE ACIDO FISOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA R1 PUEDE SER VARIOS RADICALES; Y R2 ES HIDROGENO O ALCOHILO C1-4. CONSISTE EN LA REACCION DE REDUCCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R1 Y R2 TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO POR TRATAMIENTO CON UN HIDRURO, TAL COMO HIDRURO DE LITIO Y DE ALUMINIO, EN PRESENCIA DE UN ACIDO DE LEWIS, TAL COMO CLORURO DE AUMINIO, EN UN DISOLVENTE INERTE A UNA TEMPERATURA ENTRE -40 GRADOS CENTIGRADOS Y 80 GRADOS CENTIGRADOS. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIAOXICA Y PSICOTROPA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8024717A FR2494693A1 (fr) | 1980-11-21 | 1980-11-21 | Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8207176A1 true ES8207176A1 (es) | 1982-09-01 |
| ES507317A0 ES507317A0 (es) | 1982-09-01 |
Family
ID=9248208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES507317A Granted ES507317A0 (es) | 1980-11-21 | 1981-11-20 | Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5) |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS57116070A (es) |
| AT (1) | AT379594B (es) |
| AU (1) | AU546924B2 (es) |
| BE (1) | BE891204A (es) |
| CA (1) | CA1162544A (es) |
| CH (1) | CH649549A5 (es) |
| DE (1) | DE3143179A1 (es) |
| DK (1) | DK515681A (es) |
| ES (1) | ES507317A0 (es) |
| FR (1) | FR2494693A1 (es) |
| GB (1) | GB2087889B (es) |
| GR (1) | GR78026B (es) |
| IE (1) | IE52160B1 (es) |
| IL (1) | IL64328A (es) |
| IT (1) | IT1195292B (es) |
| LU (1) | LU83775A1 (es) |
| NL (1) | NL8105282A (es) |
| NO (1) | NO813945L (es) |
| NZ (1) | NZ199008A (es) |
| PT (1) | PT74019B (es) |
| SE (1) | SE8106918L (es) |
| ZA (1) | ZA818082B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2527210A1 (fr) * | 1982-05-18 | 1983-11-25 | Synthelabo | Enantiomeres d'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de) (naphtyridine-1,5), leur procede de separation et leur application en therapeutique |
| JPH02180885A (ja) * | 1988-09-01 | 1990-07-13 | Glaxo Group Ltd | ラクタム誘導体 |
| CN113214250B (zh) * | 2021-04-28 | 2022-06-14 | 华南理工大学 | 一种稠合六氢-1,6-萘啶类化合物的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD129791A5 (de) * | 1976-04-13 | 1978-02-08 | Synthelabo | Verfahren zur herstellung von naphtyridinderivaten |
| GB1550496A (en) * | 1976-12-31 | 1979-08-15 | Logeais Labor Jacques | 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications |
-
1980
- 1980-11-21 FR FR8024717A patent/FR2494693A1/fr active Granted
-
1981
- 1981-10-30 DE DE19813143179 patent/DE3143179A1/de not_active Withdrawn
- 1981-11-17 GR GR66585A patent/GR78026B/el unknown
- 1981-11-19 LU LU83775A patent/LU83775A1/fr unknown
- 1981-11-20 NZ NZ199008A patent/NZ199008A/en unknown
- 1981-11-20 ZA ZA818082A patent/ZA818082B/xx unknown
- 1981-11-20 JP JP56187652A patent/JPS57116070A/ja active Pending
- 1981-11-20 IL IL64328A patent/IL64328A/xx unknown
- 1981-11-20 IT IT25212/81A patent/IT1195292B/it active
- 1981-11-20 IE IE2722/81A patent/IE52160B1/en unknown
- 1981-11-20 AU AU77700/81A patent/AU546924B2/en not_active Ceased
- 1981-11-20 CH CH7460/81A patent/CH649549A5/fr not_active IP Right Cessation
- 1981-11-20 CA CA000390531A patent/CA1162544A/en not_active Expired
- 1981-11-20 DK DK515681A patent/DK515681A/da not_active Application Discontinuation
- 1981-11-20 PT PT74019A patent/PT74019B/pt unknown
- 1981-11-20 BE BE0/206615A patent/BE891204A/fr not_active IP Right Cessation
- 1981-11-20 NO NO813945A patent/NO813945L/no unknown
- 1981-11-20 SE SE8106918A patent/SE8106918L/xx not_active Application Discontinuation
- 1981-11-20 AT AT0501381A patent/AT379594B/de not_active IP Right Cessation
- 1981-11-20 GB GB8135005A patent/GB2087889B/en not_active Expired
- 1981-11-20 ES ES507317A patent/ES507317A0/es active Granted
- 1981-11-23 NL NL8105282A patent/NL8105282A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO813945L (no) | 1982-05-24 |
| FR2494693A1 (fr) | 1982-05-28 |
| NZ199008A (en) | 1984-07-31 |
| IL64328A0 (en) | 1982-02-28 |
| IT8125212A0 (it) | 1981-11-20 |
| BE891204A (fr) | 1982-05-21 |
| PT74019A (fr) | 1981-12-01 |
| JPS57116070A (en) | 1982-07-19 |
| DK515681A (da) | 1982-05-22 |
| CA1162544A (en) | 1984-02-21 |
| AT379594B (de) | 1986-01-27 |
| IE52160B1 (en) | 1987-07-22 |
| GB2087889A (en) | 1982-06-03 |
| IE812722L (en) | 1982-05-21 |
| FR2494693B1 (es) | 1983-03-04 |
| NL8105282A (nl) | 1982-06-16 |
| AU7770081A (en) | 1982-05-27 |
| GR78026B (es) | 1984-09-26 |
| ZA818082B (en) | 1982-10-27 |
| DE3143179A1 (de) | 1982-06-24 |
| IL64328A (en) | 1985-02-28 |
| LU83775A1 (fr) | 1983-09-01 |
| ATA501381A (de) | 1985-06-15 |
| GB2087889B (en) | 1984-01-25 |
| CH649549A5 (fr) | 1985-05-31 |
| AU546924B2 (en) | 1985-09-26 |
| SE8106918L (sv) | 1982-05-22 |
| PT74019B (fr) | 1983-12-07 |
| IT1195292B (it) | 1988-10-12 |
| ES507317A0 (es) | 1982-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL57648A (en) | 2-substituted-5,9-dimethyl-2'-hydroxy-6,7-benzomorphanes,their preparation and pharmaceutical compositions containing them | |
| GR3018387T3 (en) | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them. | |
| ES473181A1 (es) | Procedimiento para la preparacion de derivados pirido -1, 2-a pirimidina | |
| ES8707243A1 (es) | Un procedimiento para preparar derivados de tienopiridona | |
| ES8707541A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina | |
| ES8303355A1 (es) | Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles. | |
| DE3177159D1 (de) | 2-oximino-2-aminothiazolylessigsaeurederivate und verfahren zu ihrer herstellung. | |
| ES8207176A1 (es) | Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5) | |
| NZ225659A (en) | Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives | |
| AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
| ES478643A1 (es) | Procedimiento de preparacion de nuevos derivados de la n-fe-nilalanina. | |
| ES474367A1 (es) | Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol. | |
| IE42672L (en) | Thieno-tetrahydropyridine derivatives | |
| DE3269247D1 (en) | Derivatives of 2-phenyl-morpholine and medical compositions | |
| NZ213780A (en) | Diphenylmethylimine derivatives and pharmaceutical compositions | |
| ES8401957A1 (es) | Procedimiento de preparacion de derivados del acido 2-tiofen-acetico. | |
| IE42992L (en) | PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES | |
| AU2742288A (en) | Novel compound effective as cerebral insufficiency improver | |
| ES8303405A1 (es) | Procedimiento de preparacion de derivados de quinidina. | |
| JPS5430198A (en) | Pyrido(2,3-b) phenothiazines | |
| DE2963679D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| DE3160719D1 (en) | Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them | |
| JPS5414961A (en) | Novel 3-hydroxyazetidine-3-carboxylic derivative | |
| JPS5436252A (en) | Novel propano-anthracene derivatives and their preparation | |
| DE3066808D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions |